BioAtla, Inc.
General ticker "BCAB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $26.2M (TTM average)
BioAtla, Inc. does not follow the US Stock Market performance with the rate: -18.1%.
Estimated limits based on current volatility of 5.0%: low 3.38$, high 3.73$
Factors to consider:
- Total employees count: 41 (-32.8%) as of 2025
- Top business risk factors: Limited operating history, Insufficient funding, Regulatory and compliance, Labor/talent shortage/retention, Geopolitical risks
- Current price 82.7% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [20.54$, 78.02$]
- 2026-12-31 to 2027-12-31 estimated range: [11.11$, 45.52$]
Financial Metrics affecting the BCAB estimates:
- Negative: with PPE of -4.2 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: Shareholder equity ratio, % of -261.71 <= 19.24
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 0 > -0.60
- Negative: negative Industry operating income (median)
Short-term BCAB quotes
Long-term BCAB plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $11.00MM | $2.00MM |
| Operating Expenses | $84.94MM | $61.30MM |
| Operating Income | $-73.94MM | $-59.30MM |
| Non-Operating Income | $4.17MM | $-0.30MM |
| R&D Expense | $63.09MM | $43.57MM |
| Income(Loss) | $-69.78MM | $-59.61MM |
| Net Income(Loss)* | $-69.78MM | $-59.61MM |
| Stockholders Equity | $14.27MM | $-36.19MM |
| Assets | $52.42MM | $13.83MM |
| Operating Cash Flow | $-71.94MM | $-48.20MM |
| Financing Cash Flow | $9.51MM | $6.28MM |
| Earnings Per Share** | $-71.83 | $-50.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.